3M Aldara “Approvable” For Basal Cell Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
3M is projecting approval of Aldara for superficial basal cell carcinoma in the second half of 2004 following receipt of an "approvable" letter.